The down-regulated 219 DEPs were mainly related to immunity and disease resistance metabolic pathways, such as complement and coagulation cascades, staphylococcus aureus infection, systemic lupus erythematosus, prion diseases, AGE-RAGE signaling pathways in diabetic complications, and pertussis. This evidence concerns the gene RENBP and staphylococcus aureus infection.